<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style...<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">n)</span></b><span style="font-family:Verdana;"> derivatives w</span><span style="font-family:Verdana;">ere</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> synthesized and characterized by </span><sup><span style="font-family:Verdana;">1</span></sup><span style="font-family:Verdana;">H, </span><sup><span style="font-family:Verdana;">13</span></sup><span style="font-family:Verdana;">C Nuclear Magnetic Resonance (NMR) spectra and High Resolution Mass Spectrometry (HRMS). The substitution w</span></span><span style="font-family:Verdana;">as</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> done in position -1 and -2 by appropriate groups. These compounds are obtained by N-alkylation reaction with thiomethyl-1</span><i><span style="font-family:Verdana;">H</span></i><span style="font-family:Verdana;">-benzimidazole intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;">. Design of intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;"> was made by condensation reaction between 2-methylbenzimidazole thiourunium salt </span><b><span style="font-family:Verdana;">(3)</span></b><span style="font-family:Verdana;"> and functionalized halides </span><b><span style="font-family:Verdana;">(4)</span></b><span style="font-family:Verdana;"> in the presence of sodium hydroxide (NaOH). Among the </span><span style="font-family:Verdana;">twenty-one compounds synthesized, ten were evaluated for their antimi</span><span style="font-family:Verdana;">crobial activity on three bacterial strains namely: </span><i><span style="font-family:Verdana;">Escherichia</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATCC 25922, </span><i><span style="font-family:Verdana;">Staphylococcus</span></i> <i><span style="font-family:Verdana;">aureus</span></i><span style="font-family:Verdana;"> ATCC 25923 and </span><i><span style="font-family:Verdana;">Pseudomonas</span></i> <i><span style="font-family:Verdana;">aeruginosa</span></i><span style="font-family:Verdana;"> ATCC 27853. Only </span><i><span style="font-family:Verdana;">E.</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATTC 25922 was susceptible to the synthesized derivatives </span><b><span style="font-family:Verdana;">5g</span></b><span style="font-family:Verdana;">, </span><b><span style="font-family:Verdana;">7f</span></b><span style="font-family:Verdana;"> and </span><b><span style="font-family:Verdana;">7h</span></b><span style="font-family:Verdana;"> with a significant antibacterial activity (CMI </span></span><span style="font-family:Verdana;">is </span><span style="font-family:Verdana;">between 250 and 500 μg/mL)</span><span style="font-family:Verdana;">.</span>展开更多
文摘<span style="font-family:Verdana;">A series of novel substituted benzimidazole </span><b><span style="font-family:Verdana;">(7a</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">n)</span></b><span style="font-family:Verdana;"> derivatives w</span><span style="font-family:Verdana;">ere</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> synthesized and characterized by </span><sup><span style="font-family:Verdana;">1</span></sup><span style="font-family:Verdana;">H, </span><sup><span style="font-family:Verdana;">13</span></sup><span style="font-family:Verdana;">C Nuclear Magnetic Resonance (NMR) spectra and High Resolution Mass Spectrometry (HRMS). The substitution w</span></span><span style="font-family:Verdana;">as</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> done in position -1 and -2 by appropriate groups. These compounds are obtained by N-alkylation reaction with thiomethyl-1</span><i><span style="font-family:Verdana;">H</span></i><span style="font-family:Verdana;">-benzimidazole intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;">. Design of intermediates </span><b><span style="font-family:Verdana;">(5a</span></b></span><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">-</span></b><b><span style="font-family:;" "=""> </span></b><b><span style="font-family:Verdana;">g)</span></b><span style="font-family:;" "=""><span style="font-family:Verdana;"> was made by condensation reaction between 2-methylbenzimidazole thiourunium salt </span><b><span style="font-family:Verdana;">(3)</span></b><span style="font-family:Verdana;"> and functionalized halides </span><b><span style="font-family:Verdana;">(4)</span></b><span style="font-family:Verdana;"> in the presence of sodium hydroxide (NaOH). Among the </span><span style="font-family:Verdana;">twenty-one compounds synthesized, ten were evaluated for their antimi</span><span style="font-family:Verdana;">crobial activity on three bacterial strains namely: </span><i><span style="font-family:Verdana;">Escherichia</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATCC 25922, </span><i><span style="font-family:Verdana;">Staphylococcus</span></i> <i><span style="font-family:Verdana;">aureus</span></i><span style="font-family:Verdana;"> ATCC 25923 and </span><i><span style="font-family:Verdana;">Pseudomonas</span></i> <i><span style="font-family:Verdana;">aeruginosa</span></i><span style="font-family:Verdana;"> ATCC 27853. Only </span><i><span style="font-family:Verdana;">E.</span></i> <i><span style="font-family:Verdana;">coli</span></i><span style="font-family:Verdana;"> ATTC 25922 was susceptible to the synthesized derivatives </span><b><span style="font-family:Verdana;">5g</span></b><span style="font-family:Verdana;">, </span><b><span style="font-family:Verdana;">7f</span></b><span style="font-family:Verdana;"> and </span><b><span style="font-family:Verdana;">7h</span></b><span style="font-family:Verdana;"> with a significant antibacterial activity (CMI </span></span><span style="font-family:Verdana;">is </span><span style="font-family:Verdana;">between 250 and 500 μg/mL)</span><span style="font-family:Verdana;">.</span>